Jason Hoitt, Chief Commercial Officer: Provention Bio PRVB Sell · Filed 23/02/14

Trade details

Type: Insider sale
Amount: $45,000
Shares · price: 4,500 sh · $10.00 a share
Held after: 0 sh
Stock: Provention Bio PRVB
Person: Jason HoittChief Commercial Officer
Trade date: 23/02/10
Filed: 23/02/14
Days to filing: 4 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Provention Bio trades, last 26 weeks

What else happened in Provention Bio around then

Filed or reported within 30 days of the trade day · 23/01/11~23/03/12

Jason Hoitt's recent trades

Jason HoittChief Patient Officer
SellStoke Therapeutics
Sell
Stoke Therapeutics
STOK
$55.1K
1,762 sh
$55.1K
Filed 03/19
Traded 03/18
Jason HoittChief Patient Officer
SellStoke Therapeutics
Sell
Stoke Therapeutics
STOK
$33.8K
1,033 sh
$33.8K
Filed 03/19
Traded 03/17
Jason HoittChief Patient Officer
SellStoke Therapeutics
Sell
Stoke Therapeutics
STOK
$25K
748 sh
$25K
Filed 03/19
Traded 03/17
Jason HoittChief Patient Officer
SellStoke Therapeutics
Sell
Stoke Therapeutics
STOK
$986
30 sh
$986
Filed 03/19
Traded 03/18
Jason HoittChief Patient Officer
SellStoke Therapeutics
Sell
Stoke Therapeutics
STOK
$4,419
139 sh
$4,419
Filed 03/19
Traded 03/18